Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Hyunhee Park

Dermatology Mill Creek, WA Doctor of Osteopathy

NPI 1477874311 CMS profile 1389701

15906 Mill Creek Blvd, Suite 105, Mill Creek, WA 98012

Open in the dashboard

General payments

$2,150

91 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Hyunhee Park of Mill Creek, WA is reported in the CMS Open Payments database as having received $2,150 across 91 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 47th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $789 26
2024 General $358 16
2023 General $493 22
2022 General $185 8
2021 General $79 4
2020 General $19 1
2019 General $227 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hyunhee Park
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Hyunhee Park were reported at $789. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Hyunhee Park Dermatology median Middle half National median
2019 $227 $454 $129–$1,240 $163
2020 $19 $235 $81–$756 $114
2021 $79 $377 $108–$1,108 $132
2022 $185 $514 $143–$1,391 $149
2023 $493 $607 $159–$1,674 $160
2024 $358 $751 $204–$1,903 $164
2025 $789 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $440 24 payments
  2. Amgen Inc. $411 6 payments
  3. Genzyme Corporation $311 10 payments
  4. Galderma Laboratories, L.P. $183 10 payments
  5. Novartis Pharmaceuticals Corporation $165 8 payments
  6. Lilly USA, LLC $131 6 payments
  7. Janssen Biotech, Inc. $99 5 payments
  8. Regeneron Healthcare Solutions, Inc. $88 3 payments
  9. Sun Pharmaceutical Industries Inc. $72 3 payments
  10. UCB, Inc. $53 3 payments
  11. Other $199 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,142 90 payments
  2. Education $8 1 payment
Products named General payments · program years 2019–2025
  1. DUPIXENT Immunology $501 16 payments
  2. Otezla $411 6 payments
  3. SKYRIZI $252 14 payments
  4. TALTZ $131 6 payments
  5. TREMFYA $99 5 payments
  6. RINVOQ $87 5 payments
  7. AKLIEF $76 4 payments
  8. ILUMYA $72 3 payments
  9. DUPIXENT Inflammation And Immunology $69 2 payments
  10. EBGLYSS $65 3 payments
  11. Other $633 35 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

278

Median for Dermatology: 534

Drug cost

$7,066

Median for Dermatology: $67,151

Branded share of claims

0%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clobetasol Propionate Generic 69 $2,563
Tacrolimus Generic 15 $1,322
Fluorouracil Generic 15 $990
Ketoconazole Generic 52 $792
Triamcinolone Acetonide Generic 35 $554
Clindamycin Phosphate Generic 14 $294
Mupirocin Generic 25 $224
Hydrocortisone Generic 24 $132
Doxycycline Hyclate Generic 16 $126
Spironolactone Generic 13 $69

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$52,594

Medicare's payments for the services billed

Medicare patients

236

Average age 75

Services billed

2,238

156 women, 80 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 57%
Arthritis 36%
Ischemic heart disease 18%
Diabetes 17%
Chronic kidney disease 17%
Depression 17%
Atrial fibrillation 15%
Heart failure 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 9 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DUPIXENT
  • GENZYME CORPORATION $92
$92 — —
AKLIEF
  • Galderma Laboratories, L.P. $58
$58 — —
ORACEA
  • Galderma Laboratories, L.P. $37
$37 — —
Otezla
  • Amgen Inc. $32
$32 — —
TREMFYA
  • Janssen Biotech, Inc. $26
$26 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 9 in the dashboard with a free account

Records

91 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record